FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214495966> ?p ?o ?g. }

• W3214495966 endingPage "376" @default.
• W3214495966 startingPage "373" @default.
• W3214495966 abstract "Severe fever with thrombocytopenia syndrome (SFTS) is a hemorrhagic fever. Patients mainly develop fever, thrombocytopenia, and leukopenia. A high case fatality rate of 16.2-47% has been reported. Vaccines and antivirals that are effective against SFTS virus (SFTSV) are not yet available in clinical practice. We previously showed that o-dihydroxybenzene is the important chemical core structure for anti-SFTSV activity. In this study, we evaluated the anti-SFTSV efficacy of 3-Hydroxy-L-tyrosine (L-DOPA), a treatment for Parkinson's disease and its enantiomer, 3-hydroxy-D-tyrosine (D-DOPA), both of which have an o-dihydroxybenzene backbone. SFTSV was preincubated with L- or D-DOPA and then inhibition of viral infection as well as viral attachment to host cells were evaluated by viral quantification. Both L- and D-DOPA inhibited SFTSV infection in a dose-dependent manner, mainly by blocking viral attachment to host cells. The half-maximal inhibitory concentration (IC50) of L-DOPA was 4.46-5.09 μM. IC50 of D-DOPA was 4.23-6.72 μM. IC50 of L-DOPA is very close to its maximum blood concentration after oral administration as a therapy for Parkinson's disease. D-DOPA, which IC50 was almost the same as that of L-DOPA, might not cause side effect. Thus, our present study demonstrated that L- and D-DOPA are potentially useful candidates for anti-SFTSV drugs." @default.
• W3214495966 created "2021-11-22" @default.
• W3214495966 creator A5014737285 @default.
• W3214495966 creator A5028624884 @default.
• W3214495966 creator A5037974736 @default.
• W3214495966 creator A5056345265 @default.
• W3214495966 creator A5059802121 @default.
• W3214495966 creator A5063198819 @default.
• W3214495966 creator A5063977229 @default.
• W3214495966 creator A5087693700 @default.
• W3214495966 date "2022-03-01" @default.
• W3214495966 modified "2023-10-15" @default.
• W3214495966 title "L-DOPA, a treatment for Parkinson's disease, and its enantiomer D-DOPA inhibit severe fever with thrombocytopenia syndrome virus infection in vitro" @default.
• W3214495966 cites W1568688309 @default.
• W3214495966 cites W2003717131 @default.
• W3214495966 cites W2048563227 @default.
• W3214495966 cites W2103612325 @default.
• W3214495966 cites W2120944446 @default.
• W3214495966 cites W2172081451 @default.
• W3214495966 cites W2308572722 @default.
• W3214495966 cites W2535247856 @default.
• W3214495966 cites W2795709317 @default.
• W3214495966 cites W3001564493 @default.
• W3214495966 cites W3009598173 @default.
• W3214495966 cites W3093826041 @default.
• W3214495966 cites W3127105994 @default.
• W3214495966 cites W3129844492 @default.
• W3214495966 cites W3145515008 @default.
• W3214495966 doi "https://doi.org/10.1016/j.jiac.2021.11.005" @default.
• W3214495966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34802888" @default.
• W3214495966 hasPublicationYear "2022" @default.
• W3214495966 type Work @default.
• W3214495966 sameAs 3214495966 @default.
• W3214495966 citedByCount "2" @default.
• W3214495966 countsByYear W32144959662023 @default.
• W3214495966 crossrefType "journal-article" @default.
• W3214495966 hasAuthorship W3214495966A5014737285 @default.
• W3214495966 hasAuthorship W3214495966A5028624884 @default.
• W3214495966 hasAuthorship W3214495966A5037974736 @default.
• W3214495966 hasAuthorship W3214495966A5056345265 @default.
• W3214495966 hasAuthorship W3214495966A5059802121 @default.
• W3214495966 hasAuthorship W3214495966A5063198819 @default.
• W3214495966 hasAuthorship W3214495966A5063977229 @default.
• W3214495966 hasAuthorship W3214495966A5087693700 @default.
• W3214495966 hasConcept C126322002 @default.
• W3214495966 hasConcept C159047783 @default.
• W3214495966 hasConcept C178790620 @default.
• W3214495966 hasConcept C185592680 @default.
• W3214495966 hasConcept C202751555 @default.
• W3214495966 hasConcept C2522874641 @default.
• W3214495966 hasConcept C2776070282 @default.
• W3214495966 hasConcept C2777752497 @default.
• W3214495966 hasConcept C2778732662 @default.
• W3214495966 hasConcept C2779271554 @default.
• W3214495966 hasConcept C2780873365 @default.
• W3214495966 hasConcept C29730261 @default.
• W3214495966 hasConcept C486523 @default.
• W3214495966 hasConcept C55493867 @default.
• W3214495966 hasConcept C71924100 @default.
• W3214495966 hasConcept C98274493 @default.
• W3214495966 hasConceptScore W3214495966C126322002 @default.
• W3214495966 hasConceptScore W3214495966C159047783 @default.
• W3214495966 hasConceptScore W3214495966C178790620 @default.
• W3214495966 hasConceptScore W3214495966C185592680 @default.
• W3214495966 hasConceptScore W3214495966C202751555 @default.
• W3214495966 hasConceptScore W3214495966C2522874641 @default.
• W3214495966 hasConceptScore W3214495966C2776070282 @default.
• W3214495966 hasConceptScore W3214495966C2777752497 @default.
• W3214495966 hasConceptScore W3214495966C2778732662 @default.
• W3214495966 hasConceptScore W3214495966C2779271554 @default.
• W3214495966 hasConceptScore W3214495966C2780873365 @default.
• W3214495966 hasConceptScore W3214495966C29730261 @default.
• W3214495966 hasConceptScore W3214495966C486523 @default.
• W3214495966 hasConceptScore W3214495966C55493867 @default.
• W3214495966 hasConceptScore W3214495966C71924100 @default.
• W3214495966 hasConceptScore W3214495966C98274493 @default.
• W3214495966 hasFunder F4320311405 @default.
• W3214495966 hasFunder F4320327408 @default.
• W3214495966 hasFunder F4320334764 @default.
• W3214495966 hasIssue "3" @default.
• W3214495966 hasLocation W32144959661 @default.
• W3214495966 hasLocation W32144959662 @default.
• W3214495966 hasOpenAccess W3214495966 @default.
• W3214495966 hasPrimaryLocation W32144959661 @default.
• W3214495966 hasRelatedWork W2172081451 @default.
• W3214495966 hasRelatedWork W2418219898 @default.
• W3214495966 hasRelatedWork W2555817394 @default.
• W3214495966 hasRelatedWork W2742170692 @default.
• W3214495966 hasRelatedWork W2911968051 @default.
• W3214495966 hasRelatedWork W2969469535 @default.
• W3214495966 hasRelatedWork W3033158722 @default.
• W3214495966 hasRelatedWork W3047374114 @default.
• W3214495966 hasRelatedWork W4221101974 @default.
• W3214495966 hasRelatedWork W4385586155 @default.
• W3214495966 hasVolume "28" @default.
• W3214495966 isParatext "false" @default.
• W3214495966 isRetracted "false" @default.
• W3214495966 magId "3214495966" @default.

• next